LEXINGTON, MASSACHUSETTS, July 10, 2008 — RainDance Technologies, Inc., a provider of innovative droplet-based solutions for human health and disease research, today announced the formation of RainDance Technologies France SARL, a wholly owned subsidiary focused on securing research partnerships in Europe. Based in Strasbourg, RainDance Technologies France SARL will begin operations by September 1, 2008.
“The creation of RainDance Technologies France SARL enhances our company’s ability to collaborate with leading European institutions engaged in drug discovery, genomics, and molecular biology research,” said Chris McNary, President and Chief Executive Officer, RainDance Technologies. “In addition, it will position our proven droplet-based technology for new business opportunities as we expand our presence in the growing European market. RainDance Technologies’ speed and simplicity will enable biomedical researchers to design experiments in ways that were previously unaffordable or unthinkable.”
To house its new subsidiary, RainDance has leased facilities at the Institut de Science et d’Ingénierie Supramoléculaires (ISIS), Université Louis Pasteur, in Strasbourg.
“Locating our offices at ISIS will continue our close relationship with Dr. Andrew Griffiths, a RainDance founder and the Director of the ISIS Chemical Biology Laboratory,” said McNary. “Dr. Griffiths is renowned for his work in the development of phage display for the selection of human antibodies for therapy, and for the development of a novel technique for selection and directed evolution of both nucleic acids and proteins. His support and guidance will be significant assets as we identify and engage in new research partnerships,” he said.
About RainDance Technologies
RainDance Technologies is pioneering the use of high-throughput microdroplet-based analysis in human health and life science research. The company’s core RainStorm™ technology generates millions of discrete droplets that can encapsulate a single molecule, cell or reaction and be digitally analyzed and sorted one at a time. The power, precision and simplicity of microdroplets enable researchers to answer complex questions with unprecedented sensitivity and quantitation. The complete RainDance solution includes automated instrumentation, customizable bioinformatics and high-value consumables and reagents for applications including targeted next-generation DNA sequencing, methylation, digital PCR and single cell analysis. Based in Lexington, Massachusetts, the company supports scientists around the world through its international sales and support operations and a global network of distributors and service providers. For more information, please visit www.RainDanceTech.com.
RainDance, RainStorm, ThunderStorm, Digital Biology are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.